Targeting β-cell preservation in prediabetes to lower cardiovascular risk: Preclinical assessment of DLK inhibition as an innovative antidiabetic approach

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Obesity, prediabetes, and insulin resistance Metabolic Syndrome, Insulin, Insulin Resistance ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology